Information Provided By:
Fly News Breaks for December 19, 2019
AZN, IQV, VEEV
Dec 19, 2019 | 09:52 EDT
KeyBanc analyst Donald Hooker said Iqvia's (IQV) announcement that AstraZeneca (AZN) will be fully deploying its Orchestrated Customer Engagement platform in the U.S. "is reportedly a direct rip-and-replacement of competitor and market share leader" Veeva Systems (VEEV), adding that Iqvia's hopes to further displace Veeva by expand its OCE relationship with Astra outside of the U.S. Iqvia disclosed 20 new OCE wins in Q3, 15 of which were reportedly head-to-head wins against Veeva and 2 of which were direct displacements, add Hooker. He has a Sector Weight rating on Iqvia shares.